NeoGenomics (MEX:NEO) E10: MXN-12.60 (As of Mar. 2026)


MEX:NEO NeoGenomics Inc MEX:NEO
71 GF Score
Price MXN176.40
GF Value MXN195.61
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is NeoGenomics E10?

NeoGenomics MEX:NEO 71 E10 is MXN-12.60 as of Mar. 2026. GuruFocus rates MEX:NEO with a GF Score™ of 71/100 and a GF Value™ of MXN195.61 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

NeoGenomics's adjusted earnings per share data for the three months ended in Mar. 2026 was MXN-2.344. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-12.60 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -32.60% per year. During the past 5 years, the average E10 Growth Rate was -61.00% per year. During the past 10 years, the average E10 Growth Rate was -21.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of NeoGenomics was 55.50% per year. The lowest was -87.60% per year. And the median was -21.60% per year.

As of today (2026-07-02), NeoGenomics's current stock price is MXN176.40. NeoGenomics's E10 for the quarter that ended in Mar. 2026 was MXN-12.60. NeoGenomics's Shiller PE Ratio of today is .


NeoGenomics  (MEX:NEO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


NeoGenomics E10 Related Terms


NeoGenomics E10 Historical Data

* Premium members only.

The historical data trend for NeoGenomics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoGenomics E10 Chart

NeoGenomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.03 -3.87 -3.19 -6.81 -7.77

NeoGenomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.38 -10.67 -10.62 -7.77 -12.60

MEX:NEO vs WGS, CDNA, PSNL: E10 Comparison

For the Diagnostics & Research subindustry, NeoGenomics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeoGenomics Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NeoGenomics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where NeoGenomics's Shiller PE Ratio falls into.


MEX:NEO
71GF Score
NeoGenomics Inc MEX:NEO
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeoGenomics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NeoGenomics's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-2.344/330.2130*330.2130
=-2.344

Current CPI (Mar. 2026) = 330.2130.

NeoGenomics Quarterly Data

per share eps CPI Adj_EPS
201606 -1.295 241.018 -1.774
201609 -1.353 241.428 -1.851
201612 -3.711 241.432 -5.076
201703 -0.941 243.801 -1.275
201706 -0.542 244.955 -0.731
201709 -1.633 246.819 -2.185
201712 0.589 246.524 0.789
201803 -0.545 249.554 -0.721
201806 1.375 251.989 1.802
201809 0.374 252.439 0.489
201812 0.072 251.233 0.095
201903 -0.582 254.202 -0.756
201906 0.384 256.143 0.495
201909 0.395 256.759 0.508
201912 1.132 256.974 1.455
202003 -1.641 258.115 -2.099
202006 -1.385 257.797 -1.774
202009 0.442 260.280 0.561
202012 2.586 260.474 3.278
202103 -3.884 264.877 -4.842
202106 11.745 271.696 14.275
202109 -3.496 274.310 -4.208
202112 -6.975 278.802 -8.261
202203 -7.964 287.504 -9.147
202206 -5.633 296.311 -6.277
202209 -6.034 296.808 -6.713
202212 -3.509 296.797 -3.904
202303 -4.506 301.836 -4.930
202306 -3.257 305.109 -3.525
202309 -2.613 307.789 -2.803
202312 -1.867 306.746 -2.010
202403 -3.485 312.332 -3.685
202406 -2.748 314.175 -2.888
202409 -2.757 315.301 -2.887
202412 -2.503 315.605 -2.619
202503 -4.092 319.799 -4.225
202506 -6.590 322.561 -6.746
202509 -3.852 324.800 -3.916
202512 -1.440 324.054 -1.467
202603 -2.344 330.213 -2.344

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of MXN-12.60 mean?
NeoGenomics (MEX:NEO) has a E10 of MXN-12.60 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on NeoGenomics and its competitors.
Is NeoGenomics' E10 too high?
NeoGenomics' current E10 is MXN-12.60. Overall, NeoGenomics has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does NeoGenomics' E10 compare to WGS and CDNA?
NeoGenomics' E10 of MXN-12.60 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on NeoGenomics and its competitors. NeoGenomics's current E10 is MXN-12.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeoGenomics stock overvalued right now?
Based on GuruFocus' analysis, NeoGenomics (MEX:NEO) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN195.61, compared to a current price of MXN176.40 — trading 9.8% below its estimated fair value. The current E10 is MXN-12.60. NeoGenomics' overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For NeoGenomics (MEX:NEO), the current E10 is MXN-12.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeoGenomics (MEX:NEO) Overvalued in 2026?

Based on GuruFocus' analysis, NeoGenomics stock appears to be undervalued. The current stock price of MXN176.40 is trading 9.8% below its estimated GF Value™ of MXN195.61. GuruFocus considers NeoGenomics to be Modestly Undervalued.

Key valuation signals for MEX:NEO:

  • E10: MXN-12.60
  • GF Value™: MXN195.61 vs. price of MXN176.40 (9.8% below fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the MEX:NEO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NeoGenomics Business Description

Other Exchanges NEO:USANG9:Germany
Address 9490 NeoGenomics Way, Fort Myers, FL, USA, 33912
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
71GF Score

Get the complete analysis for MEX:NEO

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN176.40
Price
MXN195.61
GF Value